PARFRESPE
Dead / Cancelled — Cancelled — Section 8 (as of 09 Aug 2019)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85622770
- Registration number
- 4271453
- Mark type
- Stylized text
- Filed
- 11 May 2012
- Published for opposition
- 23 Oct 2012
- Registered
- 08 Jan 2013
- Attorney of record
- Susan Upton Douglass
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, anti-infective preparations, preparations for the treatment of respiratory diseases, cardiovascular diseases, diabetes, cancer, arthritis, osteoporosis, and diseases of the central nervous system
Owner
- Aventis Pharma S.A., Antony, FR
- Aventis Pharma S.A., Antony, FR
- Aventis Pharma S.A., Antony, FR
Prior registrations
Prosecution history
- 09 Aug 2019 — CANCELLED SEC. 8 (6-YR)
- 08 Jan 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jan 2013 — REGISTERED-PRINCIPAL REGISTER
- 23 Oct 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Oct 2012 — PUBLISHED FOR OPPOSITION
- 03 Oct 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Sept 2012 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 14 Sept 2012 — ASSIGNED TO LIE
- 05 Sept 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Sept 2012 — EXAMINER'S AMENDMENT ENTERED
- 05 Sept 2012 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Sept 2012 — EXAMINERS AMENDMENT E-MAILED
- 05 Sept 2012 — EXAMINERS AMENDMENT -WRITTEN